Global aminoglycoside market is expected to reach
USD 1.68 billion by 2022 growing at an estimated CAGR of 3.5% from 2015 to
2022, according to a new report by Grand View Research, Inc. This expected
growth in demand can be ascribed to the increasing incidences of animal disease
outbreaks leading to high utilization of antibiotics.
However, reduction in prescription rate of
aminoglycoside antibiotics due to side effects associated with usage of these
drugs that include severe ototoxicity, nephrotoxicity, and neuromuscular
blockade are expected to affect the market growth negatively. Furthermore,
regulatory disapproval for the usage of certain aminoglycoside in regions is
also anticipated to attribute for subordinate growth in this industry.
Browse full research report on Aminoglycosides
Market:
https://www.grandviewresearch.com/industry-analysis/aminoglycoside-market
Further key
findings from the report suggest:
- Neomycin and tobramycin together contributed
for over USD 600 million as revenue in this market owing to higher usage
and prescription of these drugs for treatment of different bacterial
infections. Neomycin finds higher usage in topical formulations for
treatment of different skin infections.
- Injectables accounted for the largest share of
revenue amongst other routes of administration owing to higher usage for
treatment of tuberculosis, MDR-TB, and XDR-TB. Use of second line anti
tuberculosis drugs such as kanamycin & capreomycin by global
organizations is attributive for generation of maximum revenue in this
segment.
- Human use for treatment of respiratory
disorders accounted for largest share in applications segment owing to
rise in global incidence of tuberculosis. Furthermore, other bacterial
infections of respiratory tract that can be treated using aminoglycoside
class of antibiotics are anticipated to contribute for expected growth in
this segment.
- Veterinary treatment is expected to boost
industrial growth in the coming years owing to higher incidence of animal
diseases outbreaks. However, these drugs have restrictive regulations for
administration to food-producing animals as it may lead to toxic effects
and resistance development on humans after consumption of animal
originated food.
- Asia Pacific was the largest market,
accounting for over 40% of revenue in aminoglycoside industry owing to,
the presence of market players in this region coupled with higher rate of
tuberculosis incidences herein.
- South Africa spearheaded growth in the MEA
market. The presence of relatively higher demand and consumption of
injectable solutions in this region because of increase in incidence rate
of MDR-TB and other drug resistant infections are some regional growth
drivers.
- Key participants of the aminoglycoside market
include Vega Pharma Ltd., Kremoint Pharma Pvt. Ltd, Xian Wison Biological
Technology Co., Ltd., Jiangxi Bolai Pharmacy Co., Ltd., Medson
Pharmaceuticals, Hangzhou Uniwise International Co., Ltd., Yi Chang
Veterinary Medicine Factory, HuvePharma, and Medico Remedies Pvt. Ltd.
- Market players are involved in the development
of products with newer formulations and lesser side effects in order to
treat eradicate bacterial infections that are resistant to other class of
antibiotics.
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/aminoglycoside-market/request/rs1
Grand
View Research has segmented aminoglycoside market on the basis of product,
route of administration, application, and region:
Aminoglycoside
Product Outlook (Market Revenue in USD Million, 2012 - 2022 )
- Neomycin
- Tobramycin
- Gentamicin
- Amikacin
- Paromomycin
- Streptomycin
- Kanamycin
- Others
Aminoglycoside
Outlook, by Route of Administration (Market Revenue in USD Million, 2012 -
2022)
- Injectables
- Feed
- Intra-mammary
- Topical
- Oral
Aminoglycoside
Application Outlook (Market Revenue in USD Million, 2012 - 2022)
- Veterinary
- Skin Infection
- Respiratory diseases
- UTI & Pelvic
Diseases
- Other diseases
Aminoglycoside
Regional Outlook (Revenue, USD Million, 2012 - 2022)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- MEA
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment